A-B 9519-PSPPVCL PharmaSuite Package P&Vaddclient ESDPS/W
The A-B 9519-PSPPVCL PharmaSuite Package P&V addclient ESDPS/W is a high-performance package designed for process control in pharmaceutical manufacturing. It offers reliable data management and process visualization capabilities to enhance operational efficiency and compliance.
Manufacturer:Rockwell Automation
Model:9519-PSPPVCL
Type:PharmaSuite Package P&V Addclient ESDPS/W
Dimensions:Varies by application
Weight:Varies by application
Certifications:Complies with FDA 21 CFR Part 11, GAMP 5
Compatibility:Compatible with Rockwell Automation’s PharmaSuite software suite
Operating Conditions:Temperature: -20°C to 60°C, Humidity: 0% to 95%, Non-condensing
The A-B 9519-PSPPVCL PharmaSuite Package P&V Addclient ESDPS/W is a high-performance module designed for process automation and safety management in the pharmaceutical industry. It offers a seamless integration with existing systems and ensures optimal performance with its advanced features.
This package includes comprehensive control solutions that meet FDA and GMP standards, providing a reliable and safe operation environment. The module supports Ethernet/IP and Modbus/TCP communication interfaces, allowing for easy connectivity with other devices and systems.
Key design highlights include its robust construction made from high-quality materials, which ensures long-lasting durability and reliability. The compact size and lightweight design make it easy to install and maintain, reducing downtime and increasing productivity.
Installation is straightforward, with clear instructions provided in the user manual. Its advanced diagnostic tools enable quick troubleshooting, minimizing downtime and maximizing operational efficiency.
With its focus on quality and reliability, the A-B 9519-PSPPVCL PharmaSuite Package P&V Addclient ESDPS/W is an essential addition to any pharmaceutical manufacturing facility looking to enhance their process automation and safety management capabilities.











There are no reviews yet.